4//SEC Filing
Kelsey Stephen Michael 4
Accession 0001610717-25-000422
CIK 0001628171other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:16 PM ET
Size
4.8 KB
Accession
0001610717-25-000422
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Sale
Common Stock
2025-12-16$76.82/sh−5,447$418,423→ 278,600 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 73,576 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001462808
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:16 PM ET
- Size
- 4.8 KB